Seven Editora
##common.pageHeaderLogo.altText##
##common.pageHeaderLogo.altText##

Contacto

  • Seven Publicações Ltda CNPJ: 43.789.355/0001-14 Rua: Travessa Aristides Moleta, 290- São José dos Pinhais/PR CEP: 83045-090
  • Contacto principal
  • Nathan Albano Valente
  • (41) 9 8836-2677
  • editora@sevenevents.com.br
  • Contacto de soporte
  • contato@sevenevents.com.br

Use of canabidiol as a treatment alternative for alzheimer's: a literature review

  • 13/04/2023
  • 13/04/2023
Vitor Martins da Silva J;
Rodrigues Andrade Reis R;
Madureira Silva L;
da Silva Mesquita D;
Eduardo Ribeiro Honório Júnior J

João Vitor Martins da Silva

Romana Rodrigues Andrade Reis

Luíza Madureira Silva

Dara da Silva Mesquita

José Eduardo Ribeiro Honório Júnior

Resumen

Alzheimer's disease is a neurodegenerative disease in which progressive memory loss occurs and presents cognitive symptoms.  Currently, the number of studies with Cannabidiol as a treatment alternative for Alzheimer's disease is growing due to its neuroprotective factor. Research indicates that cannabidiol has the ability to control microglial and neuroinflammation function, favoring the survival rate of cells by combining its anti-inflammatory, antioxidant and neuroprotective effects, which act against toxicity caused by the accumulation of beta-amyloid peptides.

 

DOI: https://doi.org/10.56238/tfisdwv1-128

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Derechos de autor 2023 João Vitor Martins da Silva, Romana Rodrigues Andrade Reis, Luíza Madureira Silva, Dara da Silva Mesquita, José Eduardo Ribeiro Honório Júnior
CHAPTER 128 (English)

##plugins.themes.gdThemes.article.Authors##

  • João Vitor Martins da Silva
  • Romana Rodrigues Andrade Reis
  • Luíza Madureira Silva
  • Dara da Silva Mesquita
  • José Eduardo Ribeiro Honório Júnior